References
Key articles
Pfeiffer CM, Sternberg MR, Zhang M, et al. Folate status in the US population 20 y after the introduction of folic acid fortification. Am J Clin Nutr. 2019 Nov 1;110(5):1088-97.Full text Abstract
Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008 Jun;29(2 suppl):S20-34. Abstract
Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol. 2006 Jul;134(2):125-36.Full text Abstract
MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991 Jul 20;338(8760):131-7. Abstract
Reference articles
1. Green R, Datta Mitra A. Megaloblastic anemias: nutritional and other causes. Med Clin North Am. 2017 Mar;101(2):297-317. Abstract
2. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006 Sep;4(3):236-41.Full text Abstract
3. McLean E, de Benoist B, Allen LH. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull. 2008 Jun;29(2 suppl):S38-51. Abstract
4. Metz J. Haematological implications of folate food fortification. S Afr Med J. 2013 Oct 11;103(12 Suppl 1):978-81. Abstract
5. Rogers LM, Cordero AM, Pfeiffer CM, et al. Global folate status in women of reproductive age: a systematic review with emphasis on methodological issues. Ann N Y Acad Sci. 2018 Nov;1431(1):35-57.Full text Abstract
6. Quinn M, Halsey J, Sherliker P, et al. Global heterogeneity in folic acid fortification policies and implications for prevention of neural tube defects and stroke: a systematic review. EClinicalMedicine. 2024 Jan;67:102366.Full text Abstract
7. Pfeiffer CM, Sternberg MR, Zhang M, et al. Folate status in the US population 20 y after the introduction of folic acid fortification. Am J Clin Nutr. 2019 Nov 1;110(5):1088-97.Full text Abstract
8. Colapinto CK, O'Connor DL, Tremblay MS. Folate status of the population in the Canadian Health Measures Survey. CMAJ. 2011 Feb 8;183(2):E100-6.Full text Abstract
9. Antony AC. Evidence for potential underestimation of clinical folate deficiency in resource-limited countries using blood tests. Nutr Rev. 2017 Aug 1;75(8):600-15. Abstract
10. Antony AC, Vora RM, Karmarkar SJ. The silent tragic reality of Hidden Hunger, anaemia, and neural-tube defects (NTDs) in India. Lancet Reg Health Southeast Asia. 2022 Nov;6:100071.Full text Abstract
11. Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008 Jun;29(2 suppl):S20-34. Abstract
12. Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol. 2006 Jul;134(2):125-36.Full text Abstract
13. Htet MK, Fahmida U, Thurnham DI, et al. Folate and vitamin B12 status and dietary intake of anaemic adolescent schoolgirls in the delta region of Myanmar. Br J Nutr. 2015 Jul;116(suppl 1):S36-41. Abstract
14. Sevitt LH, Hoffbrand AV. Serum folate and vitamin B12 levels in acute and chronic renal disease. Effect of peritoneal dialysis. Br Med J. 1969 Apr 5;2(5648):18-21.Full text Abstract
15. Tu YR, Tu KH, Lee CC, et al. Supplementation with folic acid and cardiovascular outcomes in end-stage kidney disease: a multi-institution cohort study. Nutrients. 2022 Oct 7;14(19):4162.Full text Abstract
16. Nazki FH, Sameer AS, Ganaie BA. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene. 2014 Jan 1;533(1):11-20. Abstract
17. Koury MJ. Abnormal erythropoiesis and the pathophysiology of chronic anemia. Blood Rev. 2014 Mar;28(2):49-66. Abstract
18. Balashova OA, Visina O, Borodinsky LN. Folate action in nervous system development and disease. Dev Neurobiol. 2018 Apr;78(4):391-402.Full text Abstract
19. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991 Jul 20;338(8760):131-7. Abstract
20. Ramakrishnan U, Grant F, Goldenberg T, et al. Effect of women's nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr Perinat Epidemiol. 2012 Jul;26(suppl 1):285-301. Abstract
21. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832-5.Full text Abstract
22. Medici V, Peerson JM, Stabler SP, et al. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease. J Hepatol. 2010 Sep;53(3):551-7.Full text Abstract
23. Gloria L, Cravo M, Camilo ME, et al. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am J Gastroenterol. 1997 Mar;92(3):485-9. Abstract
24. Mackey AD, Picciano MF. Maternal folate status during extended lactation and the effect of supplemental folic acid. Am J Clin Nutr. 1999 Feb;69(2):285-92.Full text Abstract
25. Wald NJ. Folic acid and neural tube defects: discovery, debate and the need for policy change. J Med Screen. 2022 Sep;29(3):138-46.Full text Abstract
26. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000 May;71(5 suppl):1295S-303S. Abstract
27. Ek J, Magnus EM. Plasma and red blood cell folate in breastfed infants. Acta Paediatr Scand. 1979 Mar;68(2):239-43. Abstract
28. Klein CJ. Nutrient requirements for preterm infant formulas. J Nutr. 2002 Jun;132(6 Suppl 1):1395S-577S. Abstract
29. Jyothi S, Misra I, Morris G, et al. Red cell folate and plasma homocysteine in preterm infants. Neonatology. 2007;92(4):264-8. Abstract
30. Carmel R. Megaloblastic anemias: disorders of impaired DNA synthesis. In: Greer JP, Foerster J, Lukens JN, et al, eds. Wintrobe's clinical hematology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1372-482.
31. Bledsoe AC, King KS, Larson JJ, et al. Micronutrient deficiencies are common in contemporary celiac disease despite lack of overt malabsorption symptoms. Mayo Clin Proc. 2019 Jul;94(7):1253-60. Abstract
32. Wani NA, Hamid A, Kaur J. Folate status in various pathophysiological conditions. IUBMB Life. 2008 Dec;60(12):834-42. Abstract
33. National Institutes of Health. Folate: fact sheet for health professionals. Nov 2022 [internet publication].Full text
34. Wilson RD, O'Connor DL. Guideline no. 427: folic acid and multivitamin supplementation for prevention of folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can. 2022 Jun;44(6):707-19. Abstract
35. US Preventive Services Task Force, Barry MJ, Nicholson WK, et al. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023 Aug 1;330(5):454-9.Full text Abstract
36. Public Health England. Folic acid: updated SACN recommendations. Jul 2017 [internet publication].Full text
37. U.S. Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: preventive medication. Aug 2023 [internet publication].Full text
38. Cordero AM, Crider KS, Rogers LM, et al. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep. 2015 Apr 24;64(15):421-3. Abstract
39. National Institute for Health and Care Excellence. Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years. Jan 2025 [internet publication].Full text
40. Bulloch RE, Wall CR, Thompson JMD, et al. Folic acid supplementation is associated with size at birth in the Screening for Pregnancy Endpoints (SCOPE) international prospective cohort study. Early Hum Dev. 2020 Aug;147:105058. Abstract
41. Lassi ZS, Salam RA, Haider BA, et al. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD006896.Full text Abstract
42. Balogun OO, da Silva Lopes K, Ota E, et al. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev. 2016 May 6;(5):CD004073.Full text Abstract
43. Keats EC, Haider BA, Tam E, et al. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019 Mar 14;(3):CD004905.Full text Abstract
44. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians. 1962;75:307-20. Abstract
45. Lin Y, Dueker SR, Follett JR, et al. Quantitation of in vivo human folate metabolism. Am J Clin Nutr. 2004 Sep;80(3):680-91.Full text Abstract
46. Green R. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull. 2008 Jun;29(2 suppl):S52-63. Abstract
47. Galloway M, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol. 2003 Dec;56(12):924-6.Full text Abstract
48. Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 Aug;166(4):496-513.Full text Abstract
49. Savage DG, Lindenbaum J, Stabler SP, et al. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994 Mar;96(3):239-46. Abstract
50. Selhub J, Jacques PF, Dallal G, et al. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull. 2008 Jun;29(2 suppl):S67-73. Abstract
51. Hussein WI, Green R, Jacobsen DW, et al. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med. 1999 Sep 7;131(5):348-51. Abstract
52. Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica. 2014 May;44(5):480-8. Abstract
53. Stover PJ, Durga J, Field MS. Folate nutrition and blood-brain barrier dysfunction. Curr Opin Biotechnol. 2017 Apr;44:146-52.Full text Abstract
54. Cordero JF, Do A, Berry RJ. Review of interventions for the prevention and control of folate and vitamin B12 deficiencies. Food Nutr Bull. 2008 Jun;29(2 suppl):S188-95. Abstract
55. Russel A, Statter M, Abzug S. Methionine-dependent formiminoglutamic acid transferase deficiency: human and experimental studies in its therapy. Hum Hered. 1977;27:205.
56. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999 Jun 28;159(12):1289-98.Full text Abstract
57. Patel A, Chanarin I. Restoration of normal red cell size after treatment in megaloblastic anaemia. Br J Haematol. 1975 May;30(1):57-63. Abstract
58. Liu L, Liu S, Wang C, et al. Folate supplementation for methotrexate therapy in patients with rheumatoid arthritis: a systematic review. J Clin Rheumatol. 2019 Aug;25(5):197-202. Abstract
59. National Institute for Health and Care Excellence. BNF for children treatment summaries. Anaemia, megaloblastic. 2019 [internet publication].Full text
60. Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008 Jan;28(1):3-13. Abstract
61. Beaudin AE, Stover PJ. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol. 2009 Apr;85(4):274-84. Abstract
62. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull. 2008 Jun;29(suppl 2):S116-25. Abstract
63. Carmel R, Green R, Rosenblatt DS, et al. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program. 2003;2003:62-81.Full text Abstract
64. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. Jul 2017 [internet publication].Full text
65. Mei W, Rong Y, Jinming L, et al. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials. Int J Clin Pract. 2010 Jan;64(2):208-15. Abstract
66. Ross JF, Belding H, Paegel BL. The development and progression of subacute combined degeneration of the spinal cord in patients with pernicious anemia treated with synthetic pteroylglutamic (folic) acid. Blood. 1948 Jan;3(1):68-90. Abstract
67. Reynolds EH. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. Eur J Clin Nutr. 2016 May;70(5):537-40. Abstract
68. Patel KR, Sobczyńska-Malefora A. The adverse effects of an excessive folic acid intake. Eur J Clin Nutr. 2017 Feb;71(2):159-63. Abstract
69. Belbasis L, Köhler CA, Stefanis N, et al. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr Scand. 2018 Feb;137(2):88-97. Abstract
70. Firth J, Carney R, Stubbs B, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2018 Oct 17;44(6):1275-92.Full text Abstract
71. Roffman JL, Lamberti JS, Achtyes E, et al. Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry. 2013 May;70(5):481-9.Full text Abstract
72. Ramaekers VT, Sequeira JM, Quadros EV. The basis for folinic acid treatment in neuro-psychiatric disorders. Biochimie. 2016 Jul;126:79-90. Abstract
73. Selhub J, Rosenberg IH. Public health significance of supplementation or fortification of grain products with folic acid. Food Nutr Bull. 2008 Jun;29(2 suppl):S173-6. Abstract
Use of this content is subject to our disclaimer